Polymerization of protein allergens with glutaraldehyde (GA) has been shown to lead to decreased local or systemic adverse reactions when used in human hyposensitization therapy. At the same time, clinical trials have revealed that their immunotherapeutic value was at least as good, and in many cases significantly better than that of the corresponding conventional native allergen extracts. Despite these advantages their mechanism of action remains unclear.;The purpose of this study was to determine the characteristics and classification of immunosuoppressive activity established as a consequence of treatment with GA-proteins.;Treatment of mice, a widely accepted animal prototype for human allergy, with GA-polymerized ovalbumin (OA-POL) led ...
Development of specific inhibitors of allergy has had limited success, in part, owing to a lack of e...
We compared the antigen-specific antibody isotypes and lymphokine secretion by CD4+ T cells in BALB/...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...
Specific immunotherapy (SIT) is the only potentially curative treatment for those allergic processes...
Abstract Background We showed previously that allergic reactivity to ovalbumin (OVA) could be regul...
Anti-αGal IgE antibodies mediate a spreading allergic condition known as αGal-syndrome (AGS). People...
[Background]: The application of specific immunotherapy to stimulate oral tolerance towards food all...
For those with allergy, vaccination with a specific allergen has often been used as a major therapeu...
The anti-allergic potential of egg white protein hydrolysates (from ovalbumin, lysozyme and ovomucoi...
Background: Subcutaneous allergen-specific immunotherapy is a standard route for the immunotherapy ...
Background: Recombinant allergens are under investigation for replacing allergen extracts in immunot...
Allergen-reactive CD4+ T cells are implicated in the pathogenesis of allergic disease. Peptide immun...
OBJECTIVE: To explore the use of β-lactoglobulin polymerized using microbial transglutaminase a...
Abstract Background Allergic asthma is an inflammatory disorder of the airways that results from ina...
Ovalbumin (OVA) is widely used in allergy research. OVA peptide 323-339 has been reported to be resp...
Development of specific inhibitors of allergy has had limited success, in part, owing to a lack of e...
We compared the antigen-specific antibody isotypes and lymphokine secretion by CD4+ T cells in BALB/...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...
Specific immunotherapy (SIT) is the only potentially curative treatment for those allergic processes...
Abstract Background We showed previously that allergic reactivity to ovalbumin (OVA) could be regul...
Anti-αGal IgE antibodies mediate a spreading allergic condition known as αGal-syndrome (AGS). People...
[Background]: The application of specific immunotherapy to stimulate oral tolerance towards food all...
For those with allergy, vaccination with a specific allergen has often been used as a major therapeu...
The anti-allergic potential of egg white protein hydrolysates (from ovalbumin, lysozyme and ovomucoi...
Background: Subcutaneous allergen-specific immunotherapy is a standard route for the immunotherapy ...
Background: Recombinant allergens are under investigation for replacing allergen extracts in immunot...
Allergen-reactive CD4+ T cells are implicated in the pathogenesis of allergic disease. Peptide immun...
OBJECTIVE: To explore the use of β-lactoglobulin polymerized using microbial transglutaminase a...
Abstract Background Allergic asthma is an inflammatory disorder of the airways that results from ina...
Ovalbumin (OVA) is widely used in allergy research. OVA peptide 323-339 has been reported to be resp...
Development of specific inhibitors of allergy has had limited success, in part, owing to a lack of e...
We compared the antigen-specific antibody isotypes and lymphokine secretion by CD4+ T cells in BALB/...
Background: Identifying therapeutic drugs that block the release or effects of T-helper type 2 (Th2)...